Clinical trials
Therapy clinical trials
Below are recruiting therapy clinical trials, each written for real people, not researchers. We’re tracking 7,173 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07206472Recruiting
Study of bempedoic acid for high cholesterol
This study observes patients with high cholesterol or mixed lipid disorders who are taking bempedoic acid, alone or with ezetimibe, to see how it works in real life. It aims to gather information that may help doctors better manage cholesterol.
Belo HorizonteAges 18 years+ - NCT07040982RecruitingPhase 1
Asciminib after cell therapy for Ph+ ALL
This trial tests the drug asciminib after a stem cell transplant or CAR T-cell therapy for adults with Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) to help prevent the cancer from coming back.
Duarte, CaliforniaAges 18 years+ - NCT07012044RecruitingPhase 1
Cedazuridine and decitabine after stem cell transplant for childhood leukemia
This trial tests if adding two chemotherapy drugs (cedazuridine and decitabine) along with a growth factor (filgrastim) can help prevent leukemia from coming back after a stem cell transplant. It is for children and young adults with high-risk acute myeloid leukemia who are in remission after transplant.
Birmingham, AlabamaAges Up to 21 years - NCT07564401RecruitingPhase 1/Phase 2
CAR-T Cell Therapy for Advanced Lung Cancer
This study tests DJI136, a new type of cell therapy that trains your immune cells to fight small cell lung cancer. The therapy targets a protein called DLL3 found on cancer cells. It's designed for patients whose cancer has returned or progressed after initial chemotherapy and immunotherapy.
Lexington, KentuckyAges 18 years+ - NCT07805265Recruiting
Balance training for sciatica from a herniated disc
This study tests whether special balance and movement exercises (called sensorimotor training) can reduce leg pain and improve walking in people with sciatica caused by a herniated disc. It compares this training to usual care, aiming to help you move more comfortably.
GamasaAges 30–55 - NCT07772401Recruiting
Ear stimulation for social anxiety disorder
This study tests whether a gentle electrical pulse through the ear can help reduce symptoms of social anxiety. It's a non-invasive treatment that may offer a new way to manage anxiety without medication.
Hangzhou, ZhejiangAges 18–70 - NCT07164846Recruiting
FES suit for recovery after injury or amputation
This trial tests a special suit that uses mild electrical stimulation to help improve muscle strength, walking, and body functions. It may help people who are at least one week past an amputation or a nervous system injury like stroke or spinal cord injury.
Jacksonville, FloridaAges 18 years+ - NCT07738432Recruiting
Motor development therapy for infants with one-sided arm weakness
This study tests a therapy to help babies aged 8 to 24 months who have weakness on one side of their body (hemiplegia) improve their arm and hand skills. The therapy focuses on encouraging the brain to adapt and learn new ways to move.
Madison, WisconsinAges 8 months–2 years - NCT07859683Recruiting
Brain stimulation and therapy for teenage OCD
This study tests whether combining brain stimulation (TMS) with exposure therapy can help reduce obsessive-compulsive symptoms in teens and young adults. It aims to see if this combination is safe and effective.
Minneapolis, MinnesotaAges 12–21 - NCT06855537RecruitingPhase 4
Treating unstable plaques that are not fully blocked
This trial compares treatments for heart patients who have a dangerous, but not fully blocking, fatty plaque in their arteries. It aims to see if treating these plaques with a stent or balloon can prevent future heart problems.
Beijing, Beijing MunicipalityAges 18–80 - NCT06223568RecruitingPhase 2
Chemotherapy with or without vaccine for HPV-related throat cancer
This trial compares standard chemotherapy alone versus chemotherapy combined with an investigational vaccine (PRGN-2009) before surgery for newly diagnosed HPV-positive oropharyngeal (throat) cancer. The goal is to see if adding the vaccine improves outcomes.
Bethesda, MarylandAges 18–120 - NCT07437963RecruitingPhase 1/Phase 2
Iberdomide plus chemoimmunotherapy for neuroblastoma that returned or did not respond
This trial tests adding a new drug called iberdomide to an existing chemoimmunotherapy regimen for children and young adults with neuroblastoma that has come back or not responded to treatment. The goal is to see if the combination is safe and more effective than current treatments.
Oakland, CaliforniaAges 1–30 - NCT06466382Recruiting
Personalized cancer therapy for advanced ovarian cancer
This trial tests whether a treatment plan tailored to your specific tumor and health can work better for advanced ovarian, peritoneal, or fallopian tube cancer. It aims to find the best therapy for each patient to improve outcomes.
Baden, Canton of AargauAges 18 years+ - NCT06220773RecruitingPhase 3
combination treatment for type 2 diabetes and high blood pressure
This study tests two new combination medicines for people who have both type 2 diabetes and high blood pressure. It looks at how well they work and how safe they are. Participants stop their current diabetes and blood pressure drugs during the trial, except for the diabetes drug metformin.
Jakarta, DKI JakartaAges 19 years+ - NCT07318584RecruitingPhase 2
Cefotetan for E. coli bloodstream infections
This study tests whether a simpler antibiotic, cefotetan, works as well as the usual treatment for E. coli bloodstream infections. It may offer an effective option with fewer side effects for some patients.
Portland, OregonAges 18 years+ - NCT07569263RecruitingPhase 1
CAR T cell therapy for brain metastases
This trial tests a new kind of cell therapy that uses your own immune cells (modified to attack cancer) to treat brain metastases. It may help people whose cancer has spread to the brain and hasn't responded to other treatments.
Gainesville, FloridaAges 18–80 - NCT06075823Recruiting
Mitral valve repair for heart failure with ATTR amyloidosis
This trial tests a clip procedure to fix a leaky heart valve in people who also have a heart condition called ATTR-CM, which can cause heart failure. The clip is placed without open-heart surgery to help improve symptoms and quality of life.
GrazAges 18 years+ - NCT06819878RecruitingPhase 3
Afimkibart for moderate to severe Crohn's disease
This study tests an experimental drug called afimkibart for people with moderate to severe Crohn's disease who haven't responded well to other treatments. The goal is to see if the drug can help control symptoms and reduce inflammation over time.
Dothan, AlabamaAges 16–80 - NCT07295522RecruitingPhase 4
Medication adjustments for women after heart failure hospitalization
This trial tests whether adjusting heart failure medications in women can improve their recovery and outcomes. It focuses on women who have been recently hospitalized for acute heart failure and are not yet on optimal medication doses.
San Donato Milanese, MILANOAges 18–85 - NCT06340568RecruitingPhase 3
Study of an experimental drug vs. chemo for recurring uterine cancer
This trial is testing an experimental therapy against standard chemotherapy for people with endometrial cancer that has come back. The study looks for a certain protein (HER2) on cancer cells to decide which treatment group you may be in.
Los Angeles, CaliforniaAges 18 years+ - NCT07333430RecruitingPhase 1
CAR-T cell therapy for relapsed or refractory multiple myeloma
This trial tests a new CAR-T cell therapy (a type of immune cell treatment) for people with multiple myeloma that has come back or not responded to several prior treatments. It aims to see if this therapy can help control the disease.
JerusalemAges 18 years+ - NCT07786415Recruiting
Posture and physical function in college students with upper cross syndrome
This study looks at how posture affects everyday function in people with a common muscle imbalance called upper cross syndrome. It may help you understand your condition better, but you must be a college student in a specific age range and have this posture issue.
CairoAges 20–29 - NCT07423975RecruitingPhase 2
Testing anakinra to improve recovery after stroke treatment
This study tests a medicine called anakinra (usually used for inflammation) to see if it helps improve recovery after a stroke caused by a blocked artery that was successfully opened with a procedure. It aims to reduce brain damage and improve outcomes for patients who still have significant symptoms after treatment.
Beijing, Beijing MunicipalityAges 18–80 - NCT07227545Recruiting
Brain stimulation study for alcohol use disorder
This study tests a non-invasive brain stimulation treatment (using a mild electrical current) to see if it can help people reduce their alcohol use. It aims to improve symptoms of alcohol use disorder, which may help with recovery.
ShanghaiAges 18–60
Hear when a new Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for therapy?
- Yes. Clin2 currently lists 7,173 recruiting therapy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a therapy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a therapy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.